Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection.
Publication
, Conference
Zaffiri, L; Hallak, R; Leonard, S; Neely, M; Hulber, A; Berry, H; Young, KA; Reynolds, JM
Published in: AMERICAN JOURNAL OF TRANSPLANTATION
2022
Duke Scholars
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
2022
Volume
22
Start / End Page
992 / 993
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Zaffiri, L., Hallak, R., Leonard, S., Neely, M., Hulber, A., Berry, H., … Reynolds, J. M. (2022). Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 22, pp. 992–993).
Zaffiri, L., R. Hallak, S. Leonard, M. Neely, A. Hulber, H. Berry, K. A. Young, and J. M. Reynolds. “Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection.” In AMERICAN JOURNAL OF TRANSPLANTATION, 22:992–93, 2022.
Zaffiri L, Hallak R, Leonard S, Neely M, Hulber A, Berry H, et al. Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection. In: AMERICAN JOURNAL OF TRANSPLANTATION. 2022. p. 992–3.
Zaffiri, L., et al. “Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 22, 2022, pp. 992–93.
Zaffiri L, Hallak R, Leonard S, Neely M, Hulber A, Berry H, Young KA, Reynolds JM. Impact of Belatacept on Clinical Outcomes in Lung Transplant Patients with Antibody-Mediated Rejection. AMERICAN JOURNAL OF TRANSPLANTATION. 2022. p. 992–993.
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
2022
Volume
22
Start / End Page
992 / 993
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences